Outcome of Cervical Lymph Nodes Dissection for Thyroid Cancer with Nodal Metastases: A Southeast Asian 3-Year Experience

Table 3

Subgroup analysis of those who had recurrence in the 3-year follow-up period among papillary thyroid cancer group (n=30).

N = 30		Recurrence n (%)		OR	p
		Yes, n=16 (37.2)	No, n= 27 (62.8)	(95% CI)
Types of LND
	Central LND n= 6	1 (16.7)	5 (83.3)		0.320
	Lateral LND n= 9	5 (55.6)	4 (44.4)	-
	Central + Lateral LND n= 15	5 (33.3)	10 (66.7)
Tumour margin clear	Yes n= 19	6 (31.6)	13 (68.4)	0.55 (0.12-2.56)	0.696
	No n= 11	5 (45.5)	6 (54.5)
LN margin clearance	Yes n= 19	7 (36.8)	12 (63.2)	1.02 (0.22-4.76)	1.000
	No n= 11	4 (36.4)	7 (63.6)
Radioiodine usage	Yes, n= 26	11 (42.3)	15 (57.7)	-	0.268
	No, n= 4	0 (0.00)	4 (100.0)
Radiotherapy	Yes, n= 3	2 (66.7)	1 (33.3)	4.00 (0.32-50.0)	0.537
	No, n= 27	9 (33.3)	18 (66.7)
Chemotherapy	Yes, n= 2	2 (100.0)	0 (0.00)	-	0.126
	No, n= 28	9 (32.1)	19 (67.9)

LND, lymph node dissection; P value calculated using Fisher Exact Test.